Company or institution

Kite Pharma, Inc.

Save Like

129 applicationsfiled 2017 to 2026

Allowance rate

69%

−6 pts vs the USPTO range 58% to 79%

Rejections before allowance

2.1

+0.5 vs the USPTO

Months to first action

24.5 mo

+5.9 vs the USPTO

Needed an RCE

54%

+27 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations50 apps

C07K Peptides28 apps

A61P Therapeutic activity of compounds13 apps

C12N Microorganisms or enzymes11 apps

G01N Investigating or analysing materials9 apps

G16H Healthcare informatics4 apps

Art units

OPAP25 apps

164417 apps

164214 apps

164313 apps

16419 apps

16478 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central26 apps

n/a

Phuong N Huynh9 apps

88%

Yan Xiao4 apps

67%

Sharon X Wen4 apps

100%

Jessica Hope Roark4 apps

50%

Peter J Reddig4 apps

75%

Peter N. Johansen3 apps

50%

Alyssa G Weston3 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Kite Pharma, Inc.73 apps

70%

Sheppard, Mullin, Richter & Hampton LLP (Kite)22 apps

67%

Barnes & Thornburg LLP (Gilead/Kite Pharma)7 apps

71%

FISH & RICHARDSON P.C. (Gilead)7 apps

100%

Kite/Arrigo, Lee, Guttman & Mouta-Bellum, LLP7 apps

50%

AMGEN INC.3 apps

67%

CYTIVA - Grogan, Tuccillo & Vanderleeden, LLP2 apps

n/a

Scully, Scott, Murphy & Presser, P.C.2 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19563168	DEVICES, SYSTEMS AND METHODS FOR ASEPTICALLY SAMPLING CELL CULTURES	2026-03-11	Pending	0	0	n/a
19561932	GENE EDITING COMBINATIONS FOR ALLOGENEIC CAR-T CELLS WITH ENHANCED IMMUNE EVASION	2026-03-10	Pending	0	0	n/a
19560901	CHIMERIC ANTIGEN RECEPTORS AND CELL THERAPIES FOR AUTOIMMUNE DISEASES	2026-03-09	Pending	0	0	n/a
15942700	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15563818	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15581038	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15299134	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15162233	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15457165	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15680718	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 129 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in